Remove Compounding Remove Immunization Remove Process Improvement Related Topics
article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

The platform could potentially forecast and design several tumour vaccines that can trigger certain immune responses to fight tumours. Additionally, the platform could produce preclinical tumour vaccine candidate compounds with strong immune activity by incorporating algorithmic feedback to streamline activity and efficacy.